Comment
doi: 10.1056/NEJMc1503223.
Factor XI antisense oligonucleotide for venous thrombosis
- PMID: 25901436
- DOI: 10.1056/NEJMc1503223
Item in Clipboard
Comment
Factor XI antisense oligonucleotide for venous thrombosis
N Engl J Med.
.
No abstract available
Comment in
-
Factor XI antisense oligonucleotide for venous thrombosis.N Engl J Med. 2015 Apr 23;372(17):1672. doi: 10.1056/NEJMc1503223. N Engl J Med. 2015. PMID: 25901434 No abstract available.
Comment on
-
Factor XI antisense oligonucleotide for prevention of venous thrombosis.N Engl J Med. 2015 Jan 15;372(3):232-40. doi: 10.1056/NEJMoa1405760. Epub 2014 Dec 7. N Engl J Med. 2015. PMID: 25482425 Free PMC article. Clinical Trial.
Similar articles
-
Factor XI antisense oligonucleotide for venous thrombosis.N Engl J Med. 2015 Apr 23;372(17):1671. doi: 10.1056/NEJMc1503223. N Engl J Med. 2015. PMID: 25901435 No abstract available.
-
Factor XI antisense oligonucleotide for venous thrombosis.N Engl J Med. 2015 Apr 23;372(17):1672. doi: 10.1056/NEJMc1503223. N Engl J Med. 2015. PMID: 25901434 No abstract available.
-
Anticoagulation therapy: Reducing factor XI with antisense oligonucleotides superior to endoxaparin for postoperative venous thromboembolism.Nat Rev Cardiol. 2015 Feb;12(2):66. doi: 10.1038/nrcardio.2014.214. Epub 2014 Dec 23. Nat Rev Cardiol. 2015. PMID: 25533800 No abstract available.
-
Factor XI and factor XII as targets for new anticoagulants.Thromb Res. 2016 May;141 Suppl 2:S40-5. doi: 10.1016/S0049-3848(16)30363-2. Thromb Res. 2016. PMID: 27207423 Review.
-
[Thromboprophylaxis in hip and knee arthroplasty. Are the new anticoagulants better than those previously used?].Ugeskr Laeger. 2005 May 23;167(21):2261-5. Ugeskr Laeger. 2005. PMID: 15962850 Review. Danish. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
